CORCEPT THERAPEUTICS INC Public Float
CORCEPT THERAPEUTICS INC (CORT) had Public Float of $6.11 billion as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $6.11B.
- 2024-06-30: Entity Public Float $2.69B.
- 2023-06-30: Entity Public Float $1.83B.
- 2022-06-30: Entity Public Float $2.06B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.11B 10-K · filed 2026-02-24 |
| 2024-06-30 | $2.69B 10-K · filed 2025-02-26 |
| 2023-06-30 | $1.83B 10-K · filed 2024-02-15 |
| 2022-06-30 | $2.06B 10-K · filed 2023-02-28 |
| 2021-06-30 | $2.12B 10-K · filed 2022-02-15 |
| 2020-06-30 | $1.63B 10-K/A · filed 2021-11-15 |
| 2019-06-30 | $1.07B 10-K · filed 2020-02-24 |
| 2018-06-30 | $1.55B 10-K · filed 2019-02-26 |
| 2017-06-30 | $1.15B 10-K · filed 2018-02-28 |
| 2016-06-30 | $427.67M 10-K · filed 2017-03-06 |
| 2015-06-30 | $423.45M 10-K · filed 2016-03-10 |
| 2014-06-30 | $184.68M 10-K · filed 2015-03-13 |
| 2013-06-30 | $111.30M 10-K · filed 2014-03-14 |
| 2012-06-30 | $241.38M 10-K · filed 2013-03-15 |
| 2011-06-30 | $200.06M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |